Bromfenac (Broksinak) — a new word in the nonsteroidal antiinflamatory drug (literature review)
Eye inflammation can be caused by different factors — allergies, infection, trauma (including surgery). It can have severe complications, last even after elimination the reason and cause the visual impairment as an outcome. Two main classes of anti-inflammatory agents (corticosteroids and nonsteroid...
Main Author: | E. A. Spiridonov |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Ophthalmology Publishing Group
2016-01-01
|
Series: | Oftalʹmologiâ |
Subjects: | |
Online Access: | https://www.ophthalmojournal.com/opht/article/view/272 |
Similar Items
-
New nonsteroidal anti-inflammatory drug in the treatment of different ocular pathology
by: A. J. Slonimskij, et al.
Published: (2016-04-01) -
A Prospective study of the effect of bromfenac on tear production
by: Chikezie Grand Ihesiulor, et al.
Published: (2019-01-01) -
Topical bromfenac for prevention and treatment of cystoid macular edema following cataract surgery: a review
by: Sheppard JD
Published: (2016-10-01) -
Clinical observation of bromfenac sodium 0.1% eye drops on cataract surgery
by: Jie Chen, et al.
Published: (2015-12-01) -
A randomized double-masked study to compare the ocular safety, tolerability, and efficacy of bromfenac 0.075% compared with vehicle in cataract surgery subjects
by: Hosseini K, et al.
Published: (2016-11-01)